EUVIMEDEUVIMED entdecken
Crossref

A Tumor‐Targeted Cascade Catalytic Nanoreactor for Microenvironment Remodeling and Photodynamic Immunotherapy

Xiang-Yu Ma, Ting Pan, Xiao-Kang Jin, Shi-Man Zhang, Xuan Zeng, Xian-Zheng Zhang iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.71205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xiang-Yu Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, & Department of Traditional Chinese Medicine of Zhongnan Ho…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Photochemotherapy, Immunotherapy, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia, glutathione (GSH) overexpression, and lactate accumulation within the solid tumor microenvironment severely constrain the efficacy of photocatalytic therapy. Here, we report a CD44‐targeted cascade nanoplatform (CNMLH) constructed via layer‐by‐layer assembly to remodel this metabolic barrier. The platform features a hollow graphitic carbon nitride (CN) core, sequentially coated with an in situ grown MnO 2 shell, an electrostatically adsorbed lactate oxidase (LOx) layer, and an outermost hyaluronic acid (HA) coating. Upon HA‐mediated internalization, the outer coating degrades to release LOx, which selectively consumes lactate to produce H 2 O 2 . Subsequently, the exposed MnO 2 shell scavenges endogenous GSH and converts the generated H 2 O 2 into O 2 . This catalytic cascade effectively disrupts the tumor's antioxidant defense system and alleviates local hypoxia. Consequently, under subsequent light irradiation, the CN core overcomes the hypoxic restriction to efficiently generate reactive oxygen species (ROS), thereby triggering robust immunogenic cell death (ICD). Both in vitro and in vivo experimental results confirm that this metabolism‐intervening strategy effectively reverses the immunosuppressive microenvironment while eliciting antitumor immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentPhotochemotherapyImmunotherapyNanoparticlesAnimalsHyaluronic AcidCell Line, TumorHumansOxidesReactive Oxygen SpeciesMiceManganese CompoundsCatalysisHydrogen PeroxideHyaluronan ReceptorsGlutathioneMice, Inbred BALB CMixed Function OxygenasesNitriles

Stichwörter der Autor:innen

immunogenic cell deathimmunotherapylactate depletionphotodynamic therapytumor microenvironment

Substanzen

Hyaluronic AcidOxidesReactive Oxygen Specieslactate 2-monooxygenaseManganese CompoundscyanogenHydrogen PeroxideHyaluronan Receptorsmanganese dioxideGlutathione

Autor:innen und Institutionen

  • Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, & Department of Traditional Chinese Medicine of Zhongnan Hospital, Wuhan University, Wuhan, P. R. China.

ORCID-Profile: Xian-Zheng Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ma, X. Y., Pan, T., Jin, X. K., Zhang, S. M., Zeng, X., & Zhang, X. Z. (2026). A Tumor‐Targeted Cascade Catalytic Nanoreactor for Microenvironment Remodeling and Photodynamic Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71205

Vancouver

Ma XY, Pan T, Jin XK, Zhang SM, Zeng X, Zhang XZ. A Tumor‐Targeted Cascade Catalytic Nanoreactor for Microenvironment Remodeling and Photodynamic Immunotherapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71205

BibTeX
@article{Ma2026,
  author = {Ma, Xiang-Yu and Pan, Ting and Jin, Xiao-Kang and Zhang, Shi-Man and Zeng, Xuan and Zhang, Xian-Zheng},
  title = {A Tumor‐Targeted Cascade Catalytic Nanoreactor for Microenvironment Remodeling and Photodynamic Immunotherapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71205}
}
Kostenlos starten →